Rivanol Salbe Ethacridinlactat‑Monohydrat 2 mg/g zur äußerlichen Anwendung Variant:25 g 12" TFT touch display with

12" TFT touch display with clear 8-channel/dual curve display and large figures

contact a doctor if symptoms persist for >2 weeks

31G – präzise für subkutane Injektionen

Possible side effects: Nausea

Suitable for standard trays according to DIN 13999 and common small sterilisers

Rivanol Salbe Ethacridinlactat‑Monohydrat 2 mg/g zur äußerlichen Anwendung Variant:25 g 12" TFT touch display withRivanol ointment with active ingredient ethacridine lactate monohydrate (2 mg per g) antiseptic for germ reduction. Acts against a large number of pathogens by inhibiting the formation of cell walls. Suitable for the external treatment of bacterial skin infections and for wound healing. Apply thinly to the affected area to prevent congestion of secretions. Recommended dosage: 3 times daily in a thin layer. Do not use for longer than 7 days without